SCHEMBL12092129

SCHEMBL12092129

CNC(=O)c1cccc(NC(=O)CSC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
SIRT5 Q9NXA8 1/20 0.52
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
GAA P10253 2/20 0.51
LMNA P02545 2/20 0.50
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
MEN1 O00255 3/20 0.48
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21765849 0.84 POLB (0.58) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL12092118 0.82 MEN1 (0.53) KMT2AALDH1A1MAPTSIRT5RAB9A
SCHEMBL11544934 0.82 ALDH1A1 (0.53) KMT2AALDH1A1MAPTSIRT5RAB9A
SCHEMBL25841169 0.79 LMNA (0.65) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL14033071 0.78 RECQL (0.68) KMT2AALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL7246958 0.78 KMT2A (0.72) KMT2AALDH1A1MAPTLMNAMEN1
SCHEMBL12060819 0.78 HDAC8 (0.58) KMT2AALDH1A1RAB9ANPC1CYP3A4
SCHEMBL10153941 0.78 TSHR (0.59) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL25834932 0.78 KDM1A (0.57) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7244561 0.76 ALDH1A1 (0.72) KMT2AALDH1A1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952147-B2 Conjugates, preparation thereof, and therapeutic use thereof SANOFI (FR) 2015-02-10 US disclosed
US-20120225089-A1 NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225089-A1 NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF ERG28, CARS1, FOLH1 KMT2A 3995/4885ALDH1A1 1912/4885MAPT 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.